ch-vacd-immunization-allergyintolerances-vs
type: ValueSet
node role: treeRoot
id:
  v: ch-vacd-immunization-allergyintolerances-vs
text:
  status:
    v: generated
  div:
    v: Generated Narrative: ValueSet ch-vacd-immunization-allergyintolerances-vs This value set includes codes based on the following rules: Include these codes as defined in http://snomed.info/sct version Not Stated (use latest from terminology server) Code Display 716186003 No known allergy (situation) 213020009 Allergy to egg protein (finding) 416098002 Allergy to drug (finding) 39579001 Anaphylaxis (disorder) 24079001 Atopic dermatitis (disorder) 863903001 Allergy to component of vaccine product (finding) 293104008 Adverse reaction to component of vaccine product (disorder) 219082005 Adverse reaction to component of vaccine product containing Vibrio cholerae antigen (disorder) 1142181004 Adverse reaction to component of vaccine product containing only Severe acute respiratory syndrome coronavirus 2 messenger ribonucleic acid (disorder) 1157106007 Adverse reaction to component of vaccine product containing only recombinant non-replicating viral vector encoding Severe acute respiratory syndrome coronavirus 2 spike protein (disorder) 1162639000 Adverse reaction to component of vaccine product containing only acellular Bordetella pertussis, Clostridium tetani, Corynebacterium diphtheriae, Haemophilus influenzae type B, Hepatitis B virus and inactivated Human poliovirus antigens (disorder) 293108006 Adverse reaction to component of vaccine product containing only Clostridium tetani and Corynebacterium diphtheriae antigens (disorder) 293109003 Adverse reaction to component of vaccine product containing only Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae antigens (disorder) 293127000 Adverse reaction to component of vaccine product containing Haemophilus influenzae type B antigen (disorder) 293126009 Adverse reaction to component of vaccine product containing Hepatitis A virus antigen (disorder) 293110008 Adverse reaction to component of vaccine product containing Hepatitis B virus antigen (disorder) 420113004 Adverse reaction to component of vacc…
url:
  v: http://fhir.ch/ig/ch-vacd/ValueSet/ch-vacd-immunization-allergyintolerances-vs
  l: ch-vacd-immunization-allergyintolerances-vs
version:
  v: 7.0.0-ballot
name:
  v: AllergiesAndIntolerancesForImmunization
title:
  v: Allergies and Intolerance values for Immunization
status:
  v: draft
experimental:
  v: false
date:
  v: 2026-06-11T13:29:29+00:00
publisher:
  v: HL7 Switzerland
contact:
  name:
    v: HL7 Switzerland
  telecom:
    system:
      v: url
    value:
      v: https://www.hl7.ch/
description:
  v: The allergies and adverse reactions which have an influence on the immunization recommendations.
jurisdiction:
  coding:
    system:
      v: urn:iso:std:iso:3166
      l: 3166
    code:
      v: CHE
copyright:
  v: CC0-1.0
compose:
  include:
    system:
      v: http://snomed.info/sct
      l: sct
    concept:
      code:
        v: 716186003
      display:
        v: No known allergy (situation)
    concept:
      code:
        v: 213020009
      display:
        v: Allergy to egg protein (finding)
    concept:
      code:
        v: 416098002
      display:
        v: Allergy to drug (finding)
    concept:
      code:
        v: 39579001
      display:
        v: Anaphylaxis (disorder)
    concept:
      code:
        v: 24079001
      display:
        v: Atopic dermatitis (disorder)
    concept:
      code:
        v: 863903001
      display:
        v: Allergy to component of vaccine product (finding)
    concept:
      code:
        v: 293104008
      display:
        v: Adverse reaction to component of vaccine product (disorder)
    concept:
      code:
        v: 219082005
      display:
        v: Adverse reaction to component of vaccine product containing Vibrio cholerae antigen (disorder)
    concept:
      code:
        v: 1142181004
      display:
        v: Adverse reaction to component of vaccine product containing only Severe acute respiratory syndrome coronavirus 2 messenger ribonucleic acid (disorder)
    concept:
      code:
        v: 1157106007
      display:
        v: Adverse reaction to component of vaccine product containing only recombinant non-replicating viral vector encoding Severe acute respiratory syndrome coronavirus 2 spike protein (disorder)
    concept:
      code:
        v: 1162639000
      display:
        v: Adverse reaction to component of vaccine product containing only acellular Bordetella pertussis, Clostridium tetani, Corynebacterium diphtheriae, Haemophilus influenzae type B, Hepatitis B virus and inactivated Human poliovirus antigens (disorder)
    concept:
      code:
        v: 293108006
      display:
        v: Adverse reaction to component of vaccine product containing only Clostridium tetani and Corynebacterium diphtheriae antigens (disorder)
    concept:
      code:
        v: 293109003
      display:
        v: Adverse reaction to component of vaccine product containing only Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae antigens (disorder)
    concept:
      code:
        v: 293127000
      display:
        v: Adverse reaction to component of vaccine product containing Haemophilus influenzae type B antigen (disorder)
    concept:
      code:
        v: 293126009
      display:
        v: Adverse reaction to component of vaccine product containing Hepatitis A virus antigen (disorder)
    concept:
      code:
        v: 293110008
      display:
        v: Adverse reaction to component of vaccine product containing Hepatitis B virus antigen (disorder)
    concept:
      code:
        v: 420113004
      display:
        v: Adverse reaction to component of vaccine product containing Influenza virus antigen (disorder)
    concept:
      code:
        v: 293125008
      display:
        v: Adverse reaction to component of vaccine product containing only Measles morbillivirus and Mumps orthorubulavirus and Rubella virus antigens (disorder)
    concept:
      code:
        v: 219096004
      display:
        v: Adverse reaction to component of vaccine product containing Measles morbillivirus antigen (disorder)
    concept:
      code:
        v: 219088009
      display:
        v: Adverse reaction to component of vaccine product containing Neisseria meningitidis antigen (disorder)
    concept:
      code:
        v: 293114004
      display:
        v: Adverse reaction to component of vaccine product containing Mumps orthorubulavirus antigen (disorder)
    concept:
      code:
        v: 293116002
      display:
        v: Adverse reaction to component of vaccine product containing Streptococcus pneumoniae antigen (disorder)
    concept:
      code:
        v: 293117006
      display:
        v: Adverse reaction to component of vaccine product containing Human poliovirus antigen (disorder)
    concept:
      code:
        v: 293118001
      display:
        v: Adverse reaction to component of vaccine product containing Rabies lyssavirus antigen (disorder)
    concept:
      code:
        v: 219084006
      display:
        v: Adverse reaction to component of vaccine product containing Clostridium tetani antigen (disorder)
    concept:
      code:
        v: 219076007
      display:
        v: Adverse reaction to component of vaccine product containing Bacillus Calmette-Guerin antigen (disorder)
    concept:
      code:
        v: 293122006
      display:
        v: Adverse reaction to component of vaccine product containing Salmonella enterica subspecies enterica serovar Typhi antigen (disorder)
    concept:
      code:
        v: 219095000
      display:
        v: Adverse reaction to component of vaccine product containing Yellow fever virus antigen (disorder)
    concept:
      code:
        v: 1162644007
      display:
        v: Adverse reaction to component of vaccine product containing only severe acute respiratory syndrome coronavirus 2 recombinant spike protein antigen (disorder)
    concept:
      code:
        v: 1217476001
      display:
        v: Anaphylaxis caused by component of vaccine product (disorder)
    concept:
      code:
        v: 293120003

v: de-CH

v: Keine Allergie bekannt

v: fr-CH

v: pas d'allergie connue

v: it-CH

v: nessuna allergia nota

v: rm-CH

v: nagina allergia enconuschenta

v: en-US

v: No known allergy

v: de-CH

v: Allergie gegen Hühnereiweiss

v: fr-CH

v: allergie aux protéines de l'œuf

v: it-CH

v: allergia alle proteine dell'uovo

v: rm-CH

v: allergia cunter alv d'ov da giaglina

v: en-US

v: Allergy to egg protein

v: de-CH

v: Medikamenten-Allergie

v: fr-CH

v: allergie aux médicaments

v: it-CH

v: allergia ai farmaci

v: rm-CH

v: allergia cunter medicaments

v: en-US

v: Allergy to drug

v: de-CH

v: Anaphylaktische Reaktion

v: fr-CH

v: réaction anaphylactique

v: it-CH

v: reazione anafilattica

v: rm-CH

v: reacziun anafilactica

v: en-US

v: Anaphylactic reaction

v: de-CH

v: Atopische Dermatitis

v: fr-CH

v: dermite atopique

v: it-CH

v: dermatite atopica

v: rm-CH

v: dermatitis atopica

v: en-US

v: Atopic dermatitis

v: de-CH

v: Allergie gegen Bestandteil eines Impfstoffs

v: fr-CH

v: allergie à un composant du vaccin

v: it-CH

v: allergia a un componente del vaccino

v: rm-CH

v: allergia cunter ina cumponenta d'in vaccin

v: en-US

v: Allergy to component of vaccine product

v: de-CH

v: Unerwünschte Wirkung eines Impfstoffs

v: fr-CH

v: effet indésirable à un vaccin

v: it-CH

v: reazione avversa a un vaccino

v: rm-CH

v: effect nungiavischà d'in vaccin

v: en-US

v: Vaccine adverse reaction

v: de-CH

v: Unerwünschte Wirkung eines Cholera-Impfstoffs

v: fr-CH

v: effet indésirable d'un vaccin contre le choléra

v: it-CH

v: reazione avversa al vaccino contro il colera

v: rm-CH

v: effect nungiavischà d'in vaccin cunter colera

v: en-US

v: Cholera vaccine adverse reaction

v: de-CH

v: Unerwünschte Wirkung eines mRNA-Impfstoffs gegen COVID-19

v: fr-CH

v: effet indésirable d'un vaccin à ARNm contre la COVID-19

v: it-CH

v: reazione avversa al vaccino a mRNA anti-COVID-19

v: rm-CH

v: effect nungiavischà d'in vaccin cunter COVID-19 mRNA

v: en-US

v: COVID-19 mRNA vaccine adverse reaction

v: de-CH

v: Unerwünschte Wirkung eines nicht replizierenden viralen Vektorimpfstoffs gegen COVID-19

v: fr-CH

v: effet indésirable d'un vaccin à vecteur viral recombinant non réplicatif contre le COVID-19

v: it-CH

v: reazione avversa al vaccino a vettore virale non replicante anti-COVID-19

v: rm-CH

v: effect nungiavischà d'in vaccin vectorial viral betg replitgant cunter COVID-19

v: en-US

v: COVID-19 non-replicating viral vector vaccine adverse reaction

v: de-CH

v: Unerwünschte Wirkung eines Diphtherie-, Pertussis (azellulär)-, Haemophilus influenzae B-, Hepatitis B- und Poliomyelitis sowie Tetanus (inaktiviert)-Impfstoffs

v: fr-CH

v: effet indésirable d'un vaccin contre la diphtérie, la coqueluche (acellulaire), Haemophilus influenzae de type B, l'hépatite B, la poliomyélite (inactivé) et le tétanos

v: it-CH

v: reazione avversa al vaccino contro la difterite, il tetano, la pertosse (acellulare), la poliomielite (inattivato), l’Haemophilus influenzae di tipo B e l’epatite B

v: rm-CH

v: effect nungiavischà d'in vaccin (inactivà) cunter difteria, la tuss chanina (acellulara), hemofilus influenza B, hepatitis B e poliomielitis sco er tetanus

v: en-US

v: Diphtheria and acellular pertussis and Haemophilus influenzae type B and hepatitis B and inactivated poliomyelitis and tetanus vaccine adverse reaction

v: de-CH

v: Unerwünschte Wirkung eines Diphtherie- und Tetanus-Impfstoffs

v: fr-CH

v: effet indésirable du vaccin contre la diphtérie et le tétanos

v: it-CH

v: reazione avversa al vaccino contro la difterite e il tetano

v: rm-CH

v: effect nungiavischà d'in vaccin cunter difteria e tetanus

v: en-US

v: Diphtheria and tetanus vaccine adverse reaction

v: de-CH

v: Unerwünschte Wirkung eines Diphtherie-, Pertussis und Tetanus-Impfstoffs

v: fr-CH

v: effet indésirable du vaccin contre la diphtérie, le tétanos et la coqueluche

v: it-CH

v: reazione avversa al vaccino contro la difterite, il tetano e la pertosse

v: rm-CH

v: effect nungiavischà d'in vaccin cunter difteria, la tuss chanina e tetanus

v: en-US

v: Diphtheria, pertussis, and tetanus vaccine adverse reaction

v: de-CH

v: Unerwünschte Wirkung eines Haemophilus influenzae B-Impfstoffs

v: fr-CH

v: effet indésirable du vaccin contre Haemophilus influenzae de type B

v: it-CH

v: reazione avversa al vaccino contro l’Haemophilus influenzae di tipo B

v: rm-CH

v: effect nungiavischà d'in vaccin cunter hemofilus influenza B

v: en-US

v: Haemophilus influenzae Type B vaccine adverse reaction

v: de-CH

v: Unerwünschte Wirkung eines Hepatitis A-Impfstoffs

v: fr-CH

v: effet indésirable du vaccin contre l'hépatite A

v: it-CH

v: reazione avversa al vaccino contro l’epatite A

v: rm-CH

v: effect nungiavischà d'in vaccin cunter hepatitis A

v: en-US

v: Hepatitis A vaccine adverse reaction

v: de-CH

v: Unerwünschte Wirkung eines Hepatitis B-Impfstoffs

v: fr-CH

v: effet indésirable du vaccin contre l'hépatite B

v: it-CH

v: reazione avversa al vaccino contro l’epatite B

v: rm-CH

v: effect nungiavischà d'in vaccin cunter hepatitis B

v: en-US

v: Hepatitis B vaccine adverse reaction

v: de-CH

v: Unerwünschte Wirkung eines Influenzavirus-Impfstoffs

v: fr-CH

v: effet indésirable du vaccin contre l'influenza

v: it-CH

v: reazione avversa al vaccino contro l’influenza

v: rm-CH

v: effect nungiavischà d'in vaccin cunter la grippa

v: en-US

v: Influenza virus vaccine adverse reaction

v: de-CH

v: Unerwünschte Wirkung eines Masern-, Mumps- und Röteln-Impfstoffs

v: fr-CH

v: effet indésirable du vaccin contre la rougeole, les oreillons et la rubéole

v: it-CH

v: reazione avversa al vaccino contro il morbillo, la parotite e la rosolia

v: rm-CH

v: effect nungiavischà d'in vaccin cunter il virustgel, il glandun e la rubella

v: en-US

v: Measles and mumps and rubella vaccine adverse reaction

v: de-CH

v: Unerwünschte Wirkung eines Masern-Impfstoffs

v: fr-CH

v: effet indésirable du vaccin antirougeoleux

v: it-CH

v: reazione avversa al vaccino contro il morbillo

v: rm-CH

v: effect nungiavischà d'in vaccin cunter il virustgel

v: en-US

v: Measles vaccine adverse reaction

v: de-CH

v: Unerwünschte Wirkung eines Meningokokken-Impfstoffs

v: fr-CH

v: effet indésirable du vaccin contre les méningocoques

v: it-CH

v: reazione avversa al vaccino contro i meningococchi

v: rm-CH

v: effect nungiavischà d'in vaccin cunter meningococcus

v: en-US

v: Meningococcal vaccine adverse reaction

v: de-CH

v: Unerwünschte Wirkung eines Mumps-Impfstoffs

v: fr-CH

v: effet indésirable du vaccin contre les oreillons

v: it-CH

v: reazione avversa al vaccino contro la parotite

v: rm-CH

v: effect nungiavischà d'in vaccin cunter il glandun

v: en-US

v: Mumps vaccine adverse reaction

v: de-CH

v: Unerwünschte Wirkung eines Pneumokokken-Impfstoffs

v: fr-CH

v: effet indésirable du vaccin contre les pneumocoques

v: it-CH

v: reazione avversa al vaccino contro gli pneumococchi

v: rm-CH

v: effect nungiavischà d'in vaccin cunter pneumococcus

v: en-US

v: Pneumococcal vaccine adverse reaction

v: de-CH

v: Unerwünschte Wirkung eines Poliomyelitis-Impfstoffs

v: fr-CH

v: effet indésirable du vaccin contre la poliomyélite

v: it-CH

v: reazione avversa al vaccino contro la poliomielite

v: rm-CH

v: effect nungiavischà d'in vaccin cunter poliomielitis

v: en-US

v: Poliomyelitis vaccine adverse reaction

v: de-CH

v: Unerwünschte Wirkung eines Tollwut-Impfstoffs

v: fr-CH

v: effet indésirable du vaccin contre la rage

v: it-CH

v: reazione avversa al vaccino contro la rabbia

v: rm-CH

v: effect nungiavischà d'in vaccin cunter la frenesia

v: en-US

v: Rabies vaccine adverse reaction

v: de-CH

v: Unerwünschte Wirkung eines Tetanus-Impfstoffs

v: fr-CH

v: effet indésirable du vaccin contre le tétanos

v: it-CH

v: reazione avversa al vaccino contro il tetano

v: rm-CH

v: effect nungiavischà d'in vaccin cunter tetanus

v: en-US

v: Tetanus vaccine adverse reaction

v: de-CH

v: Unerwünschte Wirkung eines Tuberkulose-Impfstoffs

v: fr-CH

v: effet indésirable du vaccin contre la tuberculose

v: it-CH

v: reazione avversa al vaccino contro la tubercolosi

v: rm-CH

v: effect nungiavischà d'in vaccin cunter tuberculosa

v: en-US

v: Adverse reaction to component of vaccine product containing Bacillus Calmette-Guerin antigen

v: de-CH

v: Unerwünschte Wirkung eines Typhus-Impfstoffs

v: fr-CH

v: effet indésirable du vaccin contre la fièvre typhoïde

v: it-CH

v: reazione avversa al vaccino contro la febbre tifoide

v: rm-CH

v: effect nungiavischà d'in vaccin cunter tifus

v: en-US

v: Typhoid vaccine adverse reaction

v: de-CH

v: Unerwünschte Wirkung eines Gelbfieber-Impfstoffs

v: fr-CH

v: effet indésirable du vaccin contre la fièvre jaune

v: it-CH

v: reazione avversa al vaccino contro la febbre gialla

v: rm-CH

v: effect nungiavischà d'in vaccin cunter la fevra melna

v: en-US

v: Yellow fever vaccine adverse reaction

v: de-CH

v: Unerwünschte Wirkung eines Covid-19-rekombinanten Spike-Protein-Antigen-Impfstoffs

v: fr-CH

v: effet indésirable du vaccin antigénique à protéine Spike recombinante contre le COVID-19

v: it-CH

v: reazione avversa al vaccino anti-COVID-19 ricombinante con antigene della proteina spike

v: rm-CH

v: effect nungiavischà d'in vaccin cunter COVID-19 cun antigens dal protein spike recumbinant

v: en-US

v: COVID-19 recombinant spike protein antigen vaccine adverse reaction

v: de-CH

v: Anaphylaktische Reaktion auf einen Impfstoff

v: fr-CH

v: réaction anaphylactique due au vaccin

v: it-CH

v: anafilassi dovuta al vaccino

v: rm-CH

v: reacziun anafilactica sin in vaccin

v: en-US

v: Anaphylaxis due to vaccine

v: Adverse reaction to component of vaccine product containing Vaccinia virus antigen (disorder)

language:
  v: de-CH
value:
  v: Unerwünschte Wirkung eines Pocken-Impfstoffs

language:
  v: fr-CH
value:
  v: effet indésirable d'un vaccin contre la variole

language:
  v: it-CH
value:
  v: effetto indesiderato di un vaccino antivaiolo

language:
  v: rm-CH
value:
  v: effect nungiavischà d'in vaccin cunter la virola

language:
  v: en-US
value:
  v: Smallpox vaccine adverse reactionerse reaction

code:
  v: 294657002
display:
  v: Allergy to component of vaccine product containing Vaccinia virus antigen (finding)
designation:
  language:
    v: de-CH
  value:
    v: Allergie gegen Pockenimpfstoff
designation:
  language:
    v: fr-CH
  value:
    v: allergie au vaccin contre la variole
designation:
  language:
    v: it-CH
  value:
    v: allergia al vaccino contro il vaiolo
designation:
  language:
    v: rm-CH
  value:
    v: allergia cunter in vaccin en virola
designation:
  language:
    v: en-US
  value:
    v: Allergy to smallpox vaccine

code:
  v: 294641002
display:
  v: Allergy to component of vaccine product containing Bacillus anthracis antigen (finding)
designation:
  language:
    v: de-CH
  value:
    v: Allergie gegen Anthrax-Impfstoff
designation:
  language:
    v: fr-CH
  value:
    v: allergie au vaccin contre le charbon
designation:
  language:
    v: it-CH
  value:
    v: allergia al vaccino contro l'antrace
designation:
  language:
    v: rm-CH
  value:
    v: allergia cunter in vaccin cunter antrax
designation:
  language:
    v: en-US
  value:
    v: Allergy to anthrax vaccine

code:
  v: 700468006
display:
  v: Allergy to component of vaccine product containing Rotavirus antigen (finding)
designation:
  language:
    v: de-CH
  value:
    v: Allergie gegen Impfstoff gegen Rotavirus
designation:
  language:
    v: fr-CH
  value:
    v: allergie au vaccin contre le rotavirus
designation:
  language:
    v: it-CH
  value:
    v: allergia al vaccino contro il Rotavirus
designation:
  language:
    v: rm-CH
  value:
    v: allergia cunter il vaccin cunter Rotavirus
designation:
  language:
    v: en-US
  value:
    v: Allergy to Rotavirus vaccine

system:
  v: http://snomed.info/sct
  l: sct
version:
  v: http://snomed.info/sct/2011000195101
concept:
  code:
    v: 1303850003
  display:
    v: Adverse reaction to component of vaccine product containing Tick-borne encephalitis virus antigen (disorder)
  designation:
    language:
      v: de-CH
    value:
      v: Unerwünschte Wirkung eines FSME-Impfstoffs
  designation:
    language:
      v: fr-CH
    value:
      v: effet indésirable du vaccin contre la FSME
  designation:
    language:
      v: it-CH
    value:
      v: reazione avversa al vaccino contro la TBE
  designation:
    language:
      v: rm-CH
    value:
      v: effect nungiavischà d'in vaccin FSME
  designation:
    language:
      v: en-US
    value:
      v: Adverse reaction to component of vaccine product containing Tick-borne encephalitis virus antigen
concept:
  code:
    v: 1303851004
  display:
    v: Adverse reaction to component of vaccine product containing Human papillomavirus antigen (disorder)
  designation:
    language:
      v: de-CH
    value:
      v: Unerwünschte Wirkung eines Humanen-Papillomaviren-Impfstoffs
  designation:
    language:
      v: fr-CH
    value:
      v: effet indésirable du vaccin contre le papillomavirus humain
  designation:
    language:
      v: it-CH
    value:
      v: reazione avversa al vaccino contro il papillomavirus umano
  designation:
    language:
      v: rm-CH
    value:
      v: effect nungiavischà d'in vaccin da pirlas da l'uman
  designation:
    language:
      v: en-US
    value:
      v: Adverse reaction to component of vaccine product containing Human papillomavirus antigen
concept:
  code:
    v: 1303852006
  display:
    v: Adverse reaction to component of vaccine product containing Human alphaherpesvirus 3 antigen (disorder)
  designation:
    language:
      v: de-CH
    value:
      v: Unerwünschte Wirkung eines Varizellen-Impfstoffs
  designation:
    language:
      v: fr-CH
    value:
      v: effet indésirable du vaccin contre la varicelle
  designation:
    language:
      v: it-CH
    value:
      v: reazione avversa al vaccino contro la varicella
  designation:
    language:
      v: rm-CH
    value:
      v: effect nungiavischà d'in vaccin cunter varizellas
  designation:
    language:
      v: en-US
    value:
      v: Adverse reaction to component of vaccine product containing Human alphaherpesvirus 3 antigen